The global automated external defibrillator market size was valued at USD 1.4 billion in 2023 and is anticipated to grow at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2030. This growth is attributed to the increasing installation of automated external defibrillators (AEDs) in public spaces, rising heart disease cases due to genetic factors, aging, poor lifestyle, and technological advancements. In addition, the prevalence of cardiac diseases is higher, resulting in a higher demand for the external defibrillator market. According to the 2024 British Heart Foundation statistical data, around 620 million people suffer from heart and circulatory diseases worldwide.
Factors such as aging, poor lifestyle habits, and genetic factors are likely to increase emergency cases of cardiac conditions, in turn leading to higher hospital admissions. The increasing number of hospital admissions to ICUs and emergency sectors shows the necessity for AEDs, contributing to overall market growth.
Moreover, government authorities are focusing on installing AEDs in public spaces to ensure basic cardiac support in emergency cases. For instance, in May 2022, the Delhi Government installed AEDs in crowded public places such as bus stations, railway stations, and supermarkets. This initiative aimed to provide help to cardiac patients during medical emergencies.
Several key market players are also focusing on technological advancement in AED devices to increase accessibility and utility to consumers. Furthermore, several companies aim to advance the technology in these devices to provide security and privacy to consumers. For instance, in November 2023, Blackberry started to deploy the QNX® real-time operating system in medical devices such as AEDs to ensure the safety and privacy of medical information inserted into AEDs. Such technological advancements in AEDs will significantly increase the demand for AEDs during the forecast period.
The market growth is highly supported by strategic initiatives undertaken by several key market players. For instance, in September 2021, ZOLL MEDICAL strategically launched three models of AEDs in the Thailand market. The company anticipated a surge in demand for AEDs in Thailand, estimating the requirement to reach 10,000 units. This initiative by ZOLL MEDICAL shows proactive steps to address the growing need for AEDs in the Thai market, highlighting a commitment to meet the region's demand for life-saving defibrillation technology.
The merger and acquisition activities in the market are moderate, enabling companies to escalate their manufacturing capacities, regional as well as product expansion, and improve competencies. For instance, in March 2023, Safe Life, a Stockholm-based firm acquired Coro Medical and AED.us to expand the manufacturing services of AEDs across the U.S.
The regulatory authorities support AED manufacturing companies and leverage the growth of the AED market. For instance, in January 203, the US FDA approved an innovative automated external defibrillator device created by Avive Solutions. This approval supports the degree of innovation in the market.
Semi-automated external defibrillators dominated the market with a share of 25.6% in 2023. This is due to the high production of innovative AEDs by manufacturers, efficiency, and availability of devices, and easy usage. Moreover, increasing regulatory approval for AED devices will likely increase the manufacturing of AEDs over the forecast period. For instance, in June 2020, Royal Phillips received approval for its automated external defibrillators (AEDs) from the Center for Devices and Radiological Health (CDRH) of the US Food and Drug Administration (FDA).
The fully automated segment is anticipated to witness the fastest CAGR over the forecast period. The advanced technique integration in AED devices, higher efficiency, and safety are likely to enhance the demand of this segment. Moreover, fully automated AEDs need less assistance for their use and provide instant support to patients suffering from sudden cardiac arrest, making it high preferable choice for consumers.
The hospital segment led the market with a revenue share of more than 26.01% in 2023. This growth is attributed to a high number of hospital admissions due to cardiac conditions, growing installations in hospitals, and strategies implemented by key manufacturers. The surge in incidences of hypertension, diabetes, and poor eating habits leading to cardiac conditions is likely to drive demand for defibrillators in hospitals. For instance, in 2023, the Arrhythmia Alliance reported that approximately 1 in 50 Americans under the age of 65 and 1 in 10 Americans over the age of 65 are impacted by atrial fibrillation on an annual basis. In addition, an estimated 1 in 2,100 individuals experience ventricular arrhythmias annually in the U.S. This notable prevalence of arrhythmia is expected to generate higher demand for automated external defibrillators, thereby catalysing market growth.
The public access segment is projected to witness the fastest CAGR over the forecast period. This is likely due to supported initiatives by governments, regulatory agencies, and healthcare institutions to increase the availability of public access AEDs. For instance, in 2021, the automated external defibrillators (Public Access) Bill was introduced in the House of Commons of the UK Parliament.
North America dominated the automated external defibrillator market with a revenue share of 42.9% in 2023. The presence of leading manufacturing players, supportive regulatory approvals, and increased public access can be attributed to the growth of this region. Moreover, several key players focus on product expansion, which further increases the growth of the AED market. For instance, in MAY 2015, Opto Circuits, an Indian company announced the launch of a new AED in Canada and America.
The automated external defibrillators (AEDs) market in the US is expected to witness the highest CAGR rate from 2024 to 2030. Government regulations mandating AEDs in schools and airports, coupled with public awareness campaigns, have led to a surge in demand for AEDs across various sectors. User-friendly features, enhanced connectivity, and innovative designs make AEDs more accessible and effective, driving demand across sectors.
The automated external defibrillators market in Europe is expected to grow notably in the coming years. This can be attributed to well-established healthcare infrastructure, large geriatric population susceptible to cardiovascular adverse events, and the local presence of key companies
The UK automated external defibrillator market held the highest market share in 2023 owing to the high prevalence of cardiovascular diseases amongst the population. As per the 2021 BMJ study, around 80% of the population of the UK diagnosed with atrial fibrillation were eligible for early rhythm control, fueling demand for automated defibrillators and driving the fastest growth in the UK market from 2024-2030.
The automated external defibrillator market in France is expected to witness significant growth from 2024 to 2030. This will be driven by high merger and acquisition activities undertaken by key market players to expand their product expansion and provide highly efficient AEDs to consumers. For instance, in January 2022, Koninklijke Philips N.V. announced its acquisition of Cardiologs, a French company to escalate its cardiac diagnostic and monitoring product offerings.
Germany automated external defibrillators (AEDs) market is projected to grow significantly. This can be attributed to several driving factors, which include high government expenditure on healthcare, a well-established healthcare infrastructure, the prevalence of the geriatric population possessing a risk of CVD adverse effects, and the local presence of key companies. The presence of strict workplace safety regulations in Germany boosts the market growth. safety, leading to the inclusion of AEDs as part of comprehensive safety protocols. German companies prioritize employee well-being, making AEDs a vital part of their safety plans, in turn, increases the demand for AEDs in the market.
Automated external defibrillators market in Asia Pacific is expected to grow lucratively. Asia Pacific automated external defibrillators market is anticipated to grow at a CAGR of 9.9%. This is due to the presence of leading companies, high adoption of external defibrillators in key markets, and growing penetration in developing markets.
China automated external defibrillators (AEDs) market is projected to rise at the fastest CAGR from 2024 to 2034. Government authorities and industries actively integrate AEDs into safety protocols, displaying a commitment to employee well-being. For instance, in October 2020, Beihing successfully installed AEDs in Xidan Subway Station.
The automated external defibrillators market in Japan dominatedwith the highest share owing to the presence of leading companies, the high adoption of external defibrillators in key markets, and the growing penetration in developing markets. For instance, in October 2021, Zoll, a part of Asahi Kasei, has an extensive portfolio and distribution network and is a leading company in the global external defibrillators market.
The automated external defibrillator market in Latin America is expected to witness significant growth over the forecast period, driven by the growing awareness about cardiac arrest and increasing regulatory frameworks to support the availability of AEDs in public & private places. According to the American Heart Association, Inc., more Latin American countries are developing supportive regulatory frameworks to increase the availability of AEDs in high-traffic locations
Brazil automated external defibrillator market is expected to witness significant growth over the forecast period, driven by the growing awareness about cardiac arrest and increasing regulatory frameworks to support the availability of AEDs in public & private places.
The automated external defibrillators market in Middle East & Africa is growing owing to the improving healthcare infrastructure, growing deployment of defibrillators, and increasing awareness about sudden cardiovascular events, and the adoption of external
defibrillators.
Saudi Arabia automated external defibrillator market is expected to grow at the fastest CAGR over the forecast period due to rapidly improving healthcare infrastructure, coupled with growing awareness of sudden cardiac events, which is fueling a surge in defibrillator deployment.
Some of the prominent key players operating in the automated external defibrillator market include Asahi Kasei Corporation, Stryker Corporation, Nihon Kohden Corporation, Koninklijke Philips NV, Safe Life, Mediana Co. Ltd, Zoll Medical Corporation. The competition between small and large key players will likely get intense over the forecast period. Furthermore, small key players are constantly adopting several strategies to sustain their position in the market. This includes mergers and acquisitions, geographic expansion, and the launch of new products to grow in the market.
The following are the leading companies in the automated external defibrillator market. These companies collectively hold the largest market share and dictate industry trends.
In January 2023, Virginia Tech University with assistance from the Virginia Tech Police Department (VTPD) and Environmental Health and Safety (EHS) owned the AEDs program throughout the Blacksburg campus. Virginia Tech Rescue Squad (VTRS) coordinates this program and monitors emergency response in healthcare practices. This program will provide life-saving support during emergency of cardiac arrest.
In July 2023, the UK government received the world’s first personal AED named as CellAED under assistance of NHS supply chain. CellAED is designed with new technology, ultra-portable and easy to use, making it more accessible and affordable for consumers.
In January 2022, Euroa, an Australian town, became a Heart-Safe Community in August 2022 by installing 10 new defibrillators (6 accessible 24/7) and training residents on emergency response. This initiative aims to improve cardiac arrest survival rates in Victoria.
Report Attribute |
Details |
Market size value in 2024 |
USD 1.51 billion |
Revenue Forecast in 2030 |
USD 2.66 billion |
Growth rate |
CAGR of 9.8% from 2024 to 2030 |
Actual data |
2018 - 2023 |
Forecast period |
2024 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2024 to 2030 |
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments Covered |
Product, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; Germany; UK; France; Italy; Spain; Denmark; Sweden; Norway; China; Japan; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait |
Key companies profiled |
Koninklijke Philips N.V.; Stryker; ZOLL Medical Corporation; Nihon Kohden Corporation; Progetti Srl; Schiller AG; MS Westfalia GmbH; AMI Italia; Bexen Cardio; Silverline Meditech Pvt. Ltd.; Mediana Co., Ltd |
Customization scope |
Free report customization (equivalent to up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global automated external defibrillator market report based on product, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Fully-automated
Semi-automated
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Pre Hospital
Public Access Market
Alternate Care Market
Home Healthcare
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
b. The global automated external defibrillator market size was estimated at USD 1.4 billion in 2023 and is expected to reach USD 1.51 billion in 2024.
b. The global automated external defibrillator market is expected to grow at a compound annual growth rate of 9.8% from 2024 to 2030 to reach USD 2.66 billion by 2030.
b. Semi-automated external defibrillators dominated the market with a share of 25.6% in 2023. This is due to the high production of innovative AEDs by manufacturers, efficiency, and availability of devices, and easy usage.
b. Some of the prominent key players operating in the automated external defibrillator market include Asahi Kasei Corporation, Stryker Corporation, Nihon Kohden Corporation, Koninklijke Philips NV, Safe Life, Mediana Co. Ltd, Zoll Medical Corporation.
b. This growth is attributed to the increasing installation of automated external defibrillators (AEDs) in public spaces, rising heart disease cases due to genetic factors, aging, poor lifestyle, and technological advancements.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."